Head and Neck Squamous Cell Carcinoma (HNSCC) Not Yet Recruiting Phase 1 Trials for DB09074 (Olaparib)

Also known as: Head and Neck Squamous Cell Carcinoma

IndicationStatusPhase
DBCOND0043665 (Head and Neck Squamous Cell Carcinoma (HNSCC))Not Yet Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03022409A Study to Investigate Biomarker Effects of Pre-Surgical Treatment With DNA Damage Repair (DDR) Agents in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)Treatment